ClinicalTrials.gg
Sign In

Erythema clinical trials

The registry lists 131 studies for Erythema across more than 10 countries. 17 are recruiting or about to start. 75 of them are mainly about Erythema (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Stevens-Johnson Syndrome too: 171 studies, 24 open.

Get an email when these change. Save the Erythema studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
90
Recruiting
9
Terminated
8
Not yet recruiting
7
Status unknown
7
Withdrawn
5

Phase

Phase 2
16
Phase 3
12
Phase 1
11
Phase 4
10
Early Phase 1
1

Where

United States
55
Germany
8
China
8
Indonesia
5
Canada
4
United Kingdom
4

Who runs them

Allergan (7) · Church & Dwight Company, Inc. (6) · VIST - Faculty of Applied Sciences (4) · ChinaNorm (4) · Northwestern University (3) · Tufts Medical Center (3) · Galderma R&D (3) · Bayer (3)

What is being tested here

Drugs under test in Erythema studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Prednisone111
Methylprednisolone111
Metronidazole101
Timolol101
Oxymetazoline046
Brimonidine013
Terbinafine002
BAY207543002
Bilastine012
Carboplatin001

Coming up

2phase 3 studies under way
8studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8, phase 3 first

Who these studies take

Of the 9 Erythema studies recruiting now, 7 (78%) set no upper age limit and 2 (22%) stop at 75 or younger. 2 (22%) take children under 18. 1 (11%) are for women only and 0 (0%) for men only; 4 (44%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
101 (11%)1 (11%)
188 (89%)8 (89%)
308 (89%)8 (89%)
409 (100%)8 (89%)
509 (100%)8 (89%)
659 (100%)8 (89%)
758 (89%)8 (89%)
857 (78%)7 (78%)

Across all 131 studies, recruiting or not: 54% stop at 75 or younger and 44% at 65; 11% take children; 17% are for women only and 1% for men only; 60% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Erythema studies take

Of 43 interventional studies with no phase under Erythema, half reached primary completion within 3 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase3 mo1–11 · 43 studies—10 mo2–24 · 23 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 131. Browse all 131 → or search them.